About this trial
The H2REST trial is a randomized, double-blind, placebo-controlled crossover study investigating the acute effects of a single dose of hydrogen-rich water (HRW) on resting metabolism in healthy young adults. Participants complete two testing sessions-receiving either HRW or placebo in a randomized order-followed by standardized metabolic testing. Primary outcomes include resting energy expenditure, respiratory exchange ratio, and substrate utilization measured via indirect calorimetry. The study aims to assess whether acute HRW intake can modulate metabolic rate and fuel preference at rest, and to explore inter-individual variability in response.
Eligibility criteria
Qualifiers
Aged 18-35 years
BMI between 18.5 and 25.0 kg/m²
Apparently healthy, with no history of chronic disease
Non-smoker, not currently using nicotine-containing products
Disqualifiers
Diagnosed metabolic, cardiovascular, respiratory, gastrointestinal, or endocrine disorders
Use of dietary supplements or medications affecting metabolism (within the past 2 weeks)
Allergy or intolerance to components of the hydrogen or placebo beverages
Pregnant or lactating
Trial design
Treatments tested in this trial
- Molecular Hydrogen
- Placebo Comparator